Avid Bioservices Inc (CDMO)

[revenue_monster]

CP. this is all great but we've been hearing similar statements for years. Go back and read transcripts from 2 years ago and i am sure you'll find something like "partnering interest remains very high and we continue to update prospective partners" at some point the words are ignored by the investment community. Steve is the little boy that cried wolf. AZN just dropped $2.5B for 55% of s company today, pphm would be foolish to walk away from a similar structure.

Quote:
Stephen Worsley: I think the exposure that we’re seeing with these 2 collaborations [AZN & MSKCC] have significantly increased who we're talking to, but also the ability for bavituximab to act in a variety of different indications. This is obviously leading to further discussions with some of the leading oncology players worldwide.

...AND...

Peregrine’s goal in partnering with these immuno-oncology leaders is to define the broader scope of utility for bavituximab. Through these collaborations, we are actively identifying a range of indications & treatments that will benefit from combination therapy with bavituximab. This will undoubtedly yields important findings in the near-term that will continue to build shareholder value. We continue our dialog with a number of other world leading pharmaceutical organizations and believe that bavituximab will continue to generate partnering interest.